The publisher · what this wall is
About PT-141 Order.
An editorial gallery of the published PT-141 record. The 'Order' is curatorial — the way studies are arranged on a wall, not a checkout.
What this is
PT-141 Order is an independent editorial project that publishes summaries of the peer-reviewed research literature on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The name says 'Order,' and we mean it the way a gallery means it: the order in which studies are arranged on a wall, read against each other, weighed. Not an order you place. The negative-space discipline of this site is deliberate — the cited evidence gets one kind of frame, the field reports another, and the two never blur. If you have landed here first, start with what PT-141 is and then walk the rest of the walls in any order you like.
How we hang the record
PT-141's evidence splits cleanly into two kinds of object, so we frame them as two kinds of object. The cited, approved-population literature — the RECONNECT Phase 3 trials, the 52-week extension, the MC4R fMRI study, the FDA label — hangs as calm, sourced placards. The lived, off-the-record community experience hangs separately, pinned and labelled as unverified, carrying no citation. A reader should never have to guess which wall they are reading.
We lead with the honest tolerability picture rather than burying it, and we keep the approval scope exact: approved for HSDD in premenopausal women only, everything else off-label. We are willing to say the effect is statistically real but clinically modest and to cite the researchers who said so first.
What the name does not mean
The 'Order' in this site's name is editorial framing — a curatorial position relative to the literature, the arrangement of an exhibit — not a claim about any service. We do not take orders, fill prescriptions, run a pharmacy, or offer consultation, treatment, or sourcing. There is no clinic behind this wall and no counter at the back.
Material sold elsewhere as 'PT-141 research chemical' is a laboratory material outside the pharmaceutical approval, and we describe it as exactly that — never as something to buy, dose, or administer. Our entire output is reading: the research, summarised, cited, and arranged so a curious non-scientist can follow it without being misled.